AMPKα modulation in cancer progression: Multilayer integrative analysis of the whole transcriptome in Asian gastric cancer

Cancer Research

Volumn 72, Issue 10, 2012, Pages 2512-2521

  Kim, Yon Hui ^a   Liang, Han ^a   Liu, Xiuping ^a   Lee, Ju Seog ^a   Cho, Jae Yong ^b   Cheong, Jae Ho ^b   Kim, Hoguen ^b   Li, Min ^c   Downey, Thomas J ^c   Dyer, Matthew D ^d   Sun, Yongming ^d   Sun, Jingtao ^d   Beasley, Ellen M ^d   Chung, Hyun Cheol ^b   Noh, Sung Hoon ^a   Weinstein, John N ^a   Liu, Chang Gong ^a   Powis, Garth ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Yonsei University College of Medicine   (South Korea)

^c Partek Inc   (United States)

^d Life Technologies Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; TRANSCRIPTOME;

AMP ACTIVATED PROTEIN KINASE ALPHA GENE; ARTICLE; ASIAN; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; EARLY CANCER; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; PRKAA2 GENE; RNA SEQUENCE; SOMATIC MUTATION; STOMACH CANCER;

AMP-ACTIVATED PROTEIN KINASES; ASIAN CONTINENTAL ANCESTRY GROUP; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; MUTATION; RNA, MESSENGER; SEQUENCE ANALYSIS; STOMACH NEOPLASMS; TRANSCRIPTOME;

EID: 84861142867     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-3870     Document Type: Article

References (39)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137-50. (Pubitemid 46655601)
2. Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008;100:1184-7.
3. Pinto C, Di Fabio F, Siena S, Cascinu S, Llimpe FLR, Ceccarelli C, et al. Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study). Ann Oncol 2007;18: 510-7. (Pubitemid 46359631)
4. Shah MA, Ramanathan RK, Ilson DH, Levnor A, D'Adamo D, O'Reilly E, et al. Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma. J Clin Oncol 2006;24:5201-6. (Pubitemid 46631363)
5. Sotiriou C, Piccart MJ. Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nature Reviews Cancer 2007;7:545-53. (Pubitemid 46985399)
6. West M, Ginsburg GS, Huang AT, Nevins JR. Embracing the complexity of genomic data for personalized medicine. Genome Res 2006;16:559-66.
7. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNAexpression analysis. Lancet Oncol 2010;11:136-46.
8. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006;103: 2257-61. (Pubitemid 43271657)
9. Cui J, Chen Y, Chou WC, Sun L, Chen L, Suo J, et al. An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer. Nucleic Acids Res 2011;39:1197-207.
10. Berger MF, Levin JZ, Vijayendran K, Sivachenko A, Adiconis X, Maguire J, et al. Integrative analysis of the melanoma transcriptome. Genome Res 2010;20:413-27.
11. Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009;10:57-63.
12. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006;34:D140-4.
13. Mortazavi A, WilliamsBA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 2008;5:621-8. (Pubitemid 351911867)
14. Cho JY, Lim JY, Cheong JH, Park YY, Yoon SL, Kim SM, et al. Gene expression signature-based prognostic risk score in gastric cancer. Clin Cancer Res 2011;17:1850-7.
15. Zeeberg BR, Feng W, Wang G, Wang MD, Fojo AT, Sunshine M, et al. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 2003;4:R28.
16. Wang K, Kan J, Yuen ST, Shi ST, Chu KM, Law S, et al. Exome sequencing identifies frequent mutation of ARID1A in molecular sub-types of gastric cancer. Nat Genet 2011;43:1219-23.
17. Kim YH, Coon A, Baker AF, Powis G. Antitumor agent PX-12 inhibits HIF-1alpha protein levels through an Nrf2/PMF-1-mediated increase in spermidine/spermine acetyl transferase. Cancer Chemother Pharmacol 2010;68:405-13.
18. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101-8. (Pubitemid 351818697)
19. Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc 1995;57:289-300.
20. Oshlack A, Robinson MD, Young MD. From RNA-seq reads to differential expression results. Genome Biol 2010;11:220.
21. Moss SF, Lee JW, Sabo E, Rubin AK, Rommel J, Westley BR, et al. Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis. Clin Cancer Res 2008;14: 4161-7.
22. Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S. p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer 1993;54: 759-64. (Pubitemid 23228606)
23. Forbes SA, Bhamra G, Bamford S, Dawson E, Kok C, Clements J, et al. The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet 2008;Chapter 10: Unit 10.11.
24. Chiang HR, Schoenfeld LW, Ruby JG, Auyeung VC, Spies N, Baek D, et al. Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev 2010;24:992-1009.
25. Liang H, Li WH. Lowly expressed human microRNA genes evolve rapidly. Mol Biol Evol 2009;26:1195-8.
26. Burchard J, Zhang C, Liu AM, Poon RT, Lee NP, Wong KF, et al. microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol Syst Biol 2010;6:402.
27. Fisslthaler B, Fleming I. Activation and signaling by the AMP-activated protein kinase in endothelial cells. Circ Res 2009;105:114-27.
28. Nader N, Ng SS, Lambrou GI, Pervanidou P, Wang Y, Chrousos GP, et al. AMPK regulates metabolic actions of glucocorticoids by phosphorylating the glucocorticoid receptor through p38 MAPK. Mol Endocrinol 2010;24:1748-64.
29. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are micro-RNA targets. Cell 2005;120:15-20. (Pubitemid 40094598)
30. Okoshi R, Ozaki T, Yamamoto H, Ando K, Koida N, Ono S, et al. Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress. J Biol Chem 2008;283:3979-87.
31. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, et al. AM-Pactivated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 2005;18:283-93. (Pubitemid 41350534)
32. Feng Z, Levine AJ. The regulation of energy metabolism and the IGF-1/ mTOR pathways by the p53 protein. Trends Cell Biol 2010;20:427-34.
33. Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell 2007;12:9-22. (Pubitemid 47001784)
34. Jalving M, Gietema JA, Lefrandt JD, de Jong S, Reyners AK, Gans RO, et al. Metformin: taking away the candy for cancer?Eur J Cancer 2010;46:2369-80.
35. Boyle JG, Salt IP, McKay GA. Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target. Diabet Med 2010;27:1097-106.
36. Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 2009; 9:563-75.
37. Armour CD, Castle JC, Chen R, Babak T, Loerch P, Jackson S, et al. Digital transcriptome profiling using selective hexamer priming for cDNA synthesis. Nat Methods 2009;6:647-9.
38. Wu Q, KimYC, Lu J, Xuan Z, Chen J, Zheng Y, et al. Poly A-transcripts expressed in HeLa cells. PLoS One 2008;3:e2803.
39. He Y, Vogelstein B, Velculescu VE, Papadopoulos N, Kinzler KW. The antisense transcriptomes of human cells. Science 2008;322:1855-7.